106 related articles for article (PubMed ID: 25548895)
1. High levels of KAP1 expression are associated with aggressive clinical features in ovarian cancer.
Cui Y; Yang S; Fu X; Feng J; Xu S; Ying G
Int J Mol Sci; 2014 Dec; 16(1):363-77. PubMed ID: 25548895
[TBL] [Abstract][Full Text] [Related]
2. KAP1 is associated with peritoneal carcinomatosis in gastric cancer.
Yokoe T; Toiyama Y; Okugawa Y; Tanaka K; Ohi M; Inoue Y; Mohri Y; Miki C; Kusunoki M
Ann Surg Oncol; 2010 Mar; 17(3):821-8. PubMed ID: 19898899
[TBL] [Abstract][Full Text] [Related]
3. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
[TBL] [Abstract][Full Text] [Related]
4. Functional role and prognostic significance of CD157 in ovarian carcinoma.
Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
[TBL] [Abstract][Full Text] [Related]
5. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma.
Sopel M; Surowiak P; Berdowska I
Folia Morphol (Warsz); 2010 Nov; 69(4):204-12. PubMed ID: 21120806
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
Lai B; Xiao Y; Pu H; Cao Q; Jing H; Liu X
Arch Gynecol Obstet; 2012 May; 285(5):1455-61. PubMed ID: 22159627
[TBL] [Abstract][Full Text] [Related]
7. Expression of KAP1 in epithelial ovarian cancer and its correlation with drug-resistance.
Hu M; Fu X; Cui Y; Xu S; Xu Y; Dong Q; Sun L
Int J Clin Exp Med; 2015; 8(10):17308-20. PubMed ID: 26770323
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
9. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
10. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
12. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
13. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
[TBL] [Abstract][Full Text] [Related]
14. The potential prognostic value of cathepsin D protein in serous ovarian cancer.
Chai Y; Wu W; Zhou C; Zhou J
Arch Gynecol Obstet; 2012 Aug; 286(2):465-71. PubMed ID: 22476353
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].
Zhang MZ; Qiao YH; Suo ZH
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):848-52. PubMed ID: 19173831
[TBL] [Abstract][Full Text] [Related]
16. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
17. Biological role and prognostic significance of NAC1 in ovarian cancer.
Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
[TBL] [Abstract][Full Text] [Related]
18. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
19. Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients.
Fitzgerald S; Sheehan KM; O'Grady A; Kenny D; O'Kennedy R; Kay EW; Kijanka GS
J Gastroenterol Hepatol; 2013 Jun; 28(6):967-74. PubMed ID: 23425061
[TBL] [Abstract][Full Text] [Related]
20. High levels of Wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer.
Liu Z; Yamanouchi K; Ohtao T; Matsumura S; Seino M; Shridhar V; Takahashi T; Takahashi K; Kurachi H
Anticancer Res; 2014 May; 34(5):2331-40. PubMed ID: 24778040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
